title: Heterogeneity of human mast cells based on cytokine content.
abstract: Human mast cells can be divided into two distinct phenotypes based on their content of neutral serine proteases, suggesting that they serve differing biologic and pathologic roles. Recently, it has been demonstrated that human mast cells are a source of several pleiotropic cytokines including IL-4, IL-5, IL-6, IL-8, and TNF-alpha, but not all mast cells contain all of these cytokines, suggesting that there is also functional heterogeneity with respect to cytokine expression. In this study, we have examined the relationship between mast cell neutral protease expression and cytokine content using immunohistochemistry. Bronchial mucosal biopsies from five normal subjects and five patients with allergic asthma, and nasal mucosal biopsies from five normal subjects and three patients with allergic rhinitis were embedded in glycol methacrylate. Sections (2 microns) were stained for IL-4, IL-5, and IL-6, adjacent to serial sections stained for tryptase and chymase. The distribution of cytokines among the tryptase+ chymase- mast cells (MCT) and tryptase+ chymase+ mast cells (MCTC) was examined by co-localization of cytokines to MCTC or MCT in serial sections using the camera-lucida. Although IL-4 was distributed among both mast cell phenotypes, it was expressed preferentially by the MCTC subset (overall 85% MCTC:15% MCT). In contrast, IL-5 and IL-6 were restricted almost exclusively to the MCT subset. Immunostaining of isolated skin mast cells (> 99% MCTC) supported these findings, with strong immunoreactivity present for IL-4 but very little for IL-5 or IL-6. These results indicate that in addition to exhibiting heterogeneity with respect to neutral protease content of the secretory granules, human mast cells are also heterogeneous with respect to cytokine content. This suggests that the biologic functions of MCTC and MCT cells differ as a result of their capacity to generate and release different cytokine profiles.
authors.affiliation: Immunopharmacology Group, University of Southampton, United Kingdom.
authors.forename: P
authors.initials: P
authors.lastname: Bradding
authors.forename: Y
authors.initials: Y
authors.lastname: Okayama
authors.forename: P H
authors.initials: PH
authors.lastname: Howarth
authors.forename: M K
authors.initials: MK
authors.lastname: Church
authors.forename: S T
authors.initials: ST
authors.lastname: Holgate
mesh_terms: D000328:Adult; D001249:Asthma / Q000276:immunology; D001980:Bronchi / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D053818:Chymases; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D015847:Interleukin-4 / Q000032:analysis; D015848:Interleukin-5 / Q000032:analysis; D015850:Interleukin-6 / Q000032:analysis; D007378:Interleukins / Q000032:analysis*; D008297:Male; D008407:Mast Cells / Q000737:chemistry* / Q000201:enzymology; D009297:Nasal Mucosa / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology; D012697:Serine Endopeptidases / Q000032:analysis; D012867:Skin / Q000276:immunology / Q000473:pathology; D053802:Tryptases
chemical_list: D015848:Interleukin-5; D015850:Interleukin-6; D007378:Interleukins; D015847:Interleukin-4; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases